Phyllis Speiser, MD, on the Endocrine Society’s Guideline for CAH Due to Steroid 21-Hydroxylase Deficiency
01/22/2020
Phyllis Speiser, MD, answers our questions about the Endocrine Society’s 2018 clinical practice guideline for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. She is chair of the guideline.
Phyllis Speiser, MD, is chief of the Division of Pediatric Endocrinology at Cohen Children’s Medical Center of New York, and professor of pediatrics at Hofstra/Northwell School of Medicine.
Reference:
Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088. https://doi.org/10.1210/jc.2018-01865.